EUVIMEDPoznaj EUVIMED
Open access · CC BY 4.0

Genotype-Phenotype of CRB1-Associated Early-Onset Retinal Dystrophy: Novel Insights on Retinal Architecture and Therapeutic Window for Clinical Trials

Yili Jin, Songshan Li, Zhaoxin Jiang, Limei Sun, Li Huang, Ting Zhang, Xinyu Liu, Xiaoyan Ding

Investigative Opthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.3.11 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, 2024. Written by Yili Jin and 7 co-authors. Institution: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Major MEDLINE topics: Retinal Dystrophies, Leber Congenital Amaurosis. Cited 8 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Purpose

The purpose of this study was to investigate the genotypic and phenotypic characteristics of CRB1-associated early onset retinal dystrophy (CRB1-eoRD) and retinal architecture by swept-source optical coherence tomography (SS-OCT).

Methods

Eleven probands with CRB1-eoRD were recruited. Clinical information, genetic analysis, and comprehensive ophthalmic examinations including SS-OCT and SS-OCT angiography (SS-OCTA) were conducted.

Results

A total of 81.8% (9/11) of CRB1-eoRD presented as Leber congenital amaurosis (LCA). Common clinical manifestations included coin-like yellow-white retinal spots (20/22, 90.9%) and para-arteriolar retinal pigment epithelial retention (12/22, 54.5%). Nineteen different CRB1 variants were detected in our case series, including 12 missense, 3 frameshifts, 3 nonsense, and 1 splicing. Of them, 12 variants had been reported, and 7 were novel. SS-OCT showed thinner central macula (the LCA group, P < 0.0001), thicker total retina (P < 0.0001), thinner outer retina (P < 0.05), and thicker inner retina (P < 0.0001) compared with the healthy control. The inner/outer (I/O) retina thickness ratio of CRB1-eoRD was 3.0, higher than the healthy control of 1.2 and other inherited retinal diseases (IRDs) of 2.2 (P < 0.0001 and P = 0.0027, respectively). SS-OCTA revealed an increased vascular density and perfusion area of the superficial vascular complex and deep vascular complex in CRB1-eoRD.

Conclusions

LCA emerges as a frequently occurring phenotype in CRB1-eoRD. The unique features of SS-OCT and SS-OCTA are illustrated, and the novel biomarker, I/O ratio, may facilitate early diagnosis. The insights gained from this study hold significant value in determining the treatment window for potential forthcoming CRB1 gene therapy.

Subjects

MeSH terms (MEDLINE)

Retinal DystrophiesLeber Congenital AmaurosisHumansRetinaGenotypePhenotypeEye ProteinsMembrane ProteinsNerve Tissue Proteins

Substances

CRB1 protein, humanEye ProteinsMembrane ProteinsNerve Tissue Proteins

Authors and institutions

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.
  • Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.

Cite

APA

Jin, Y., Li, S., Jiang, Z., Sun, L., Huang, L., Zhang, T., Liu, X., & Ding, X. (2024). Genotype-Phenotype of CRB1-Associated Early-Onset Retinal Dystrophy: Novel Insights on Retinal Architecture and Therapeutic Window for Clinical Trials. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.3.11

Vancouver

Jin Y, Li S, Jiang Z, Sun L, Huang L, Zhang T, et al. Genotype-Phenotype of CRB1-Associated Early-Onset Retinal Dystrophy: Novel Insights on Retinal Architecture and Therapeutic Window for Clinical Trials. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.3.11

BibTeX
@article{Jin2024,
  author = {Jin, Yili and Li, Songshan and Jiang, Zhaoxin and Sun, Limei and Huang, Li and Zhang, Ting and Liu, Xinyu and Ding, Xiaoyan},
  title = {Genotype-Phenotype of CRB1-Associated Early-Onset Retinal Dystrophy: Novel Insights on Retinal Architecture and Therapeutic Window for Clinical Trials},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.3.11}
}
Start for free →